Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Upcoming Events

View all
View all
View all
View all
View all
PDA ANSI

PDA and the American National Standards Institute (ANSI)

Read more
What's New
  • New online content just added to the PDA Letter! Find out what deep learning means for visual inspection. 
  • An EU task force focused on preventing drug shortages has posted its work program for the next two years.
  • EMA expects to lose approximately 30 percent of staff as a result of relocating the headquarters from London to Amsterdam.
  • The U.S. FDA recently published a notice that bumetanide, nicardipine hydrochloride, and vasopressin should not be placed on the list of bulk drug substances that can be compounded.
2019 PDA BoD
Newsfeed
Buyer’s Guide
Become a Member
Lori Richter Volunteer Spotlight Volunteer of the Month is Lori Richter
PDA Education

Advertisers

Continue the Conversation @PDA ConnectSM An Interactive Online Community!
PDA Career Center
Open Positions

Director of Regulatory Affairs

This is a non-supervisory role that directs and manages PDA volunteer-driven project activities.

 
Read more

About PDA

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.

Read more

PDA Letter Free Articles